Ozkok S, Ozkok A. Contrast-induced acute kidney injury: a review of practical points. World J Nephrol. 2017;6(3):86–99.

Article  PubMed  PubMed Central  Google Scholar 

Seeliger E, Sendeski M, Rihal CS, Persson PB. Contrast-induced kidney injury: mechanisms, risk factors, and prevention. EUR HEART J. 2012;33(16):2007–15.

Article  PubMed  Google Scholar 

Nijssen EC, Rennenberg RJ, Nelemans PJ, Essers BA, Janssen MM, Vermeeren MA, Ommen VV, Wildberger JE. Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): a prospective, randomised, phase 3, controlled, open-label, non-inferiority trial. Lancet. 2017;389(10076):1312–22.

Article  PubMed  Google Scholar 

Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. NEPHRON. 2012;120(4):c179–84.

PubMed  Google Scholar 

van der Molen AJ, Reimer P, Dekkers IA, Bongartz G, Bellin MF, Bertolotto M, Clement O, Heinz-Peer G, Stacul F, Webb J, et al. Post-contrast acute kidney injury - part 1: definition, clinical features, incidence, role of contrast medium and risk factors: recommendations for updated ESUR Contrast Medium Safety Committee guidelines. EUR RADIOL. 2018;28(7):2845–55.

Article  PubMed  PubMed Central  Google Scholar 

Davenport MS, Perazella MA, Yee J, Dillman JR, Fine D, McDonald RJ, Rodby RA, Wang CL, Weinreb JC. Use of Intravenous Iodinated Contrast Media in Patients with Kidney Disease: Consensus Statements from the American College of Radiology and the National Kidney Foundation. RADIOLOGY 2020, 294(3):660–668.

Lameire N, Kellum JA. Contrast-induced acute kidney injury and renal support for acute kidney injury: a KDIGO summary (part 2). CRIT CARE. 2013;17(1):205.

Article  PubMed  PubMed Central  Google Scholar 

van der Molen AJ, Reimer P, Dekkers IA, Bongartz G, Bellin MF, Bertolotto M, Clement O, Heinz-Peer G, Stacul F, Webb J, et al. Post-contrast acute kidney injury. Part 2: risk stratification, role of hydration and other prophylactic measures, patients taking metformin and chronic dialysis patients: recommendations for updated ESUR Contrast Medium Safety Committee guidelines. EUR RADIOL. 2018;28(7):2856–69.

Article  PubMed  PubMed Central  Google Scholar 

Wanner C, Inzucchi SE, Lachin JM, Fitchett D, von Eynatten M, Mattheus M, Johansen OE, Woerle HJ, Broedl UC, Zinman B. Empagliflozin and progression of kidney disease in type 2 diabetes. NEW ENGL J MED. 2016;375(4):323–34.

Article  CAS  PubMed  Google Scholar 

Stratta P, Quaglia M, Airoldi A, Aime S. Structure-function relationships of iodinated contrast media and risk of nephrotoxicity. CURR MED CHEM. 2012;19(5):736–43.

Article  CAS  PubMed  Google Scholar 

Spampinato MV, Abid A, Matheus MG. Current Radiographic Iodinated contrast agents. MAGN RESON IMAGING C. 2017;25(4):697–704.

Article  Google Scholar 

Thomsen HS, Morcos SK. Prevention of generalized reactions to CM. ACAD RADIOL. 2002;9(Suppl 2):S433–5.

Article  PubMed  Google Scholar 

Stacul F, van der Molen AJ, Reimer P, Webb JA, Thomsen HS, Morcos SK, Almen T, Aspelin P, Bellin MF, Clement O, et al. Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines. EUR RADIOL. 2011;21(12):2527–41.

Article  PubMed  Google Scholar 

Kellum JA, Lameire N. Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (part 1). CRIT CARE. 2013;17(1):204.

Article  PubMed  PubMed Central  Google Scholar 

Chen Y, Chen J, Fu G, Du Z, Fang Q, Cui L, et al. Chinese expert consensus on adverse reactions related to iodide contrast angiography. Chin J Intervention Cardiol. 2014;22(06):341–8.

Google Scholar 

Mehta RL, Cerda J, Burdmann EA, Tonelli M, Garcia-Garcia G, Jha V, Susantitaphong P, Rocco M, Vanholder R, Sever MS, et al. International Society of Nephrology’s 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology. Lancet. 2015;385(9987):2616–43.

Article  PubMed  Google Scholar 

Maeder M, Klein M, Fehr T, Rickli H. Contrast nephropathy: review focusing on prevention. J AM COLL CARDIOL. 2004;44(9):1763–71.

Article  PubMed  Google Scholar 

Chandiramani R, Cao D, Nicolas J, Mehran R. Contrast-induced acute kidney injury. CARDIOVASC INTERV TH. 2020;35(3):209–17.

Article  Google Scholar 

Azzalini L, Spagnoli V, Ly HQ. Contrast-Induced Nephropathy: from pathophysiology to preventive strategies. CAN J CARDIOL. 2016;32(2):247–55.

Article  PubMed  Google Scholar 

Bucaloiu ID, Kirchner HL, Norfolk ER, Hartle JN, Perkins RM. Increased risk of death and de novo chronic kidney disease following reversible acute kidney injury. KIDNEY INT. 2012;81(5):477–85.

Article  PubMed  Google Scholar 

Moos SI, van Vemde DN, Stoker J, Bipat S. Contrast induced nephropathy in patients undergoing intravenous (IV) contrast enhanced computed tomography (CECT) and the relationship with risk factors: a meta-analysis. EUR J RADIOL. 2013;82(9):e387–99.

Article  PubMed  Google Scholar 

Kooiman J, Pasha SM, Zondag W, Sijpkens YW, van der Molen AJ, Huisman MV, Dekkers OM. Meta-analysis: serum creatinine changes following contrast enhanced CT imaging. EUR J RADIOL. 2012;81(10):2554–61.

Article  PubMed  Google Scholar 

Tepel M, Aspelin P, Lameire N. Contrast-induced nephropathy: a clinical and evidence-based approach. Circulation. 2006;113(14):1799–806.

Article  PubMed  Google Scholar 

Azzalini L. The clinical significance and management implications of chronic total occlusion Associated with Surgical Coronary Artery Revascularization. CAN J CARDIOL. 2016;32(11):1286–9.

Article  PubMed  Google Scholar 

Scharnweber T, Alhilali L, Fakhran S. Contrast-Induced Acute kidney Injury: pathophysiology, manifestations, Prevention, and management. MAGN RESON IMAGING C. 2017;25(4):743–53.

Article  Google Scholar 

Kusirisin P, Chattipakorn SC, Chattipakorn N. Contrast-induced nephropathy and oxidative stress: mechanistic insights for better interventional approaches. J TRANSL MED. 2020;18(1):400.

Article  PubMed  PubMed Central  Google Scholar 

Heyman SN, Rosen S, Khamaisi M, Idee JM, Rosenberger C. Reactive oxygen species and the pathogenesis of radiocontrast-induced nephropathy. INVEST RADIOL. 2010;45(4):188–95.

Article  PubMed  Google Scholar 

Hardiek K, Katholi RE, Ramkumar V, Deitrick C. Proximal tubule cell response to radiographic contrast media. AM J PHYSIOL-RENAL. 2001;280(1):F61–70.

Article  CAS  Google Scholar 

McCullough PA, Choi JP, Feghali GA, Schussler JM, Stoler RM, Vallabahn RC, Mehta A. Contrast-Induced Acute kidney Injury. J AM COLL CARDIOL. 2016;68(13):1465–73.

Article  PubMed  Google Scholar 

Zager RA, Johnson AC, Hanson SY. Radiographic contrast media-induced tubular injury: evaluation of oxidant stress and plasma membrane integrity. KIDNEY INT. 2003;64(1):128–39.

Article  CAS  PubMed  Google Scholar 

Liu GL, Lei R, Duan SB, Tang MM, Luo M, Xu Q. Atorvastatin alleviates iodinated contrast media-induced cytotoxicity in human proximal renal tubular epithelial cells. EXP THER MED. 2017;14(4):3309–13.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sendeski MM. Pathophysiology of renal tissue damage by iodinated contrast media. CLIN EXP PHARMACOL P. 2011;38(5):292–9.

Article  CAS  Google Scholar 

Huang S, Tang Y, Liu T, Zhang N, Yang X, Yang D, Hong G. A novel antioxidant protects against contrast Medium-Induced Acute kidney Injury in rats. FRONT PHARMACOL. 2020;11:599577.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ward DB, Brown KC, Valentovic MA. Radiocontrast Agent Diatrizoic Acid induces Mitophagy and oxidative stress via Calcium Dysregulation. INT J MOL SCI 2019, 20(17).

Hu C, Zhou G, Liu K, Yin W, Zhou L, Wang J, Chen L, Zuo S, Xie Y, Zuo X. CaMKII as a key regulator of contrast-induced nephropathy through mPTP opening in HK-2 cells. CELL SIGNAL. 2020;75:109734.

Article  CAS  PubMed  Google Scholar 

Caiazza A, Russo L, Sabbatini M, Russo D. Hemodynamic and tubular changes induced by contrast media. BIOMED RES INT 2014, 2014:578974.

Heyman SN, Rosen S, Rosenberger C. Renal parenchymal hypoxia, hypoxia adaptation, and the pathogenesis of radiocontrast nephropathy. CLIN J AM SOC NEPHRO. 2008;3(1):288–96.

Article  Google Scholar 

Dugbartey GJ, Redington AN. Prevention of contrast-induced nephropathy by limb ischemic preconditioning: underlying mechanisms and clinical effects. AM J PHYSIOL-RENAL. 2018;314(3):F319–28.

Article  Google Scholar 

Wong PC, Li Z, Guo J, Zhang A. Pathophysiology of contrast-induced nephropathy. INT J CARDIOL. 2012;158(2):186–92.

Article  PubMed  Google Scholar 

Heyman SN, Brezis M, Epstein FH, Spokes K, Silva P, Rosen S. Early renal medullary hypoxic injury from radiocontrast and indomethacin. KIDNEY INT. 1991;40(4):632–42.

Article  CAS  PubMed  Google Scholar 

Mamoulakis C, Tsarouhas K, Fragkiadoulaki I, Heretis I, Wilks MF, Spandidos DA, Tsitsimpikou C, Tsatsakis A. Contrast-induced nephropathy: basic concepts, pathophysiological implications and prevention strategies. PHARMACOL THERAPEUT. 2017;180:99–112.

Article  CAS  Google Scholar 

Bucher AM, De Cecco CN, Schoepf UJ, Meinel FG, Krazinski AW, Spearman JV, McQuiston AD, Wang R, Bucher J, Vogl TJ, et al. Is contrast medium osmolality a causal factor for contrast-induced nephropathy? BIOMED RES INT. 2014;2014:931413.

Article  PubMed  PubMed Central